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Abstract
Viral replication efficiency is in large part governed by the ability of viruses to counteract pro-apoptotic signals induced by
infection of the host cell. Human herpesvirus 8 (HHV-8) uses several strategies to block the host’s innate antiviral defenses
via interference with interferon and apoptotic signaling. Contributors include the four viral interferon regulatory factors
(vIRFs 1–4), which function in dominant negative fashion to block cellular IRF activities in addition to targeting IRF signaling-
induced proteins such as p53 and inhibiting other inducers of apoptosis such as TGFb receptor-activated Smad transcription
factors. Here we identify direct targeting by vIRF-1 of BH3-only pro-apoptotic Bcl-2 family member Bim, a key negative
regulator of HHV-8 replication, to effect its inactivation via nuclear translocation. vIRF-1-mediated relocalization of Bim was
identified in transfected cells, by both immunofluorescence assay and western analysis of fractionated cell extracts. Also, co-
localization of vIRF-1 and Bim was detected in nuclei of lytically infected endothelial cells. In vitro co-precipitation assays
using purified vIRF-1 and Bim revealed direct interaction between the proteins, and Bim-binding residues of vIRF-1 were
mapped by deletion and point mutagenesis. Generation and experimental utilization of Bim-refractory vIRF-1 variants
revealed the importance of vIRF-1:Bim interaction, specifically, in pro-replication and anti-apoptotic activity of vIRF-1.
Furthermore, blocking of the interaction with cell-permeable peptide corresponding to the Bim-binding region of vIRF-1
confirmed the relevance of vIRF-1:Bim association to vIRF-1 pro-replication activity. To our knowledge, this is the first report
of an IRF protein that interacts with a Bcl-2 family member and of nuclear sequestration of Bim or any other member of the
family as a means of inactivation. The data presented reveal a novel mechanism utilized by a virus to control replication-
induced apoptosis and suggest that inhibitory targeting of vIRF-1:Bim interaction may provide an effective antiviral strategy.
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Introduction
Human herpesvirus 8 (HHV-8) is associated with the endothe-
lial tumor Kaposi’s sarcoma in addition to the B cell malignancies
primary effusion lymphoma (PEL) and multicentric Castleman’s
disease [1–3]. Several genes, including vIRF-1, have been noted to
have oncogenic capacity in culture and in in vivo models [4,5].
However, most of these genes are expressed during productive,
lytic replication, suggesting that they do not play direct roles in
malignant pathogenesis, but rather serve to enhance virus
production. Oncogenic properties such as promotion of prolifer-
ative signaling pathways and cell survival are indeed consistent
with putative roles in establishing conditions that are conducive to
virus productive replication. For example, the viral IRFs function
to block innate cellular responses of cell cycle arrest and apoptosis
that would be induced by virus replication [6–8], and these
properties, functioning normally to promote virus replication,
could also be pro-oncogenic in experimental systems. Of note is
that vIRF-1 can bind to and inhibit interferon-activated apoptotic
effector proteins such as p53 and GRIM19 [(gene for) retinoid-
IFN-induced mortality 19] in addition to p53-activating ATM
[9–11]. In contrast to investigations of pro-survival and pro-
tumorigenic activities of the vIRFs, studies of the functions of these
proteins in normal virus biology, and in particular their roles
during lytic replication, are lacking, although it is speculated that
they do indeed function to enhance virus production by
countering innate cellular defenses.
Previous studies from this laboratory noted the importance of
the pro-apoptotic BH3-only protein Bim in negative regulation of
HHV-8 productive replication in endothelial cells [12]. The viral
chemokines vCCL-1 and vCCL-2 were found to induce signal
transduction in endothelial cells leading to the repression of Bim
induction following starvation-mediated stress and to promote
virus replication, effected via both endogenously produced and
exogenously added v-chemokines. The central relevance of Bim to
productive replication of HHV-8 was indicated more directly by
the demonstration that HHV-8 production was massively
increased in cells depleted of Bim via shRNA transduction [12].
In this system, the positive effects of vCCL-1 and vCCL-2 were
abrogated, suggesting that these viral chemokines exert pro-
replication effects via control of lytic cycle-induced Bim expres-
sion, thereby acting to inhibit apoptosis and allow a window for
virus production.
Bim is induced by a number of stress factors, such as nutrient
deprivation, growth factor withdrawal, U.V. irradiation and anti-
tumor drugs, in addition to stress induced by virus replication [13].
The classical model of Bim activation is via JNK-mediated
phosphorylation, of long (BimL) and extra-long (BimEL) splice-
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complexes, allowing translocation of the BH3-only protein to
mitochondria [14,15]. Disruption of Bim-cytoskeletal sequestra-
tion can also be mediated via induction of Gadd45, regulated by
p53 and a mediator of cell cycle arrest and apoptosis [16]; Gadd45
may promote Bim release in part through activation of JNK kinase
MEKK4. At mitochondria, Bim triggers apoptosis via interactions
with anti-apoptotic Bcl-2 proteins to relieve suppression of Bax/
Bak apoptotic effector oligomerization and pore formation in
mitochondrial membranes. In addition to cytoplasmic sequestra-
tion via dynein motor association, negative regulation of BimEL
can be effected by AKT and ERK phosphorylation, leading to 14-
3-3 cytosolic sequestration and proteasomal degradation of Bim,
respectively [17–19]. The short isoform of Bim, BimS, lacks all
phosphorylation sites (JNK, AKT and ERK targets) and therefore
cannot be regulated like its larger counterparts. However, in
contrast to these proteins, expression of BimS appears to be highly
restricted in vivo, and its precise role remains unclear [20,21].
Here we identify a novel mechanism of Bim inactivation, via
nuclear sequestration, mediated by HHV-8 vIRF-1. The data
presented suggest that disruption of such regulation could provide
a unique and useful means of controlling HHV-8 productive
replication.
Results
Identification of nuclear-localized Bim
Whilst we previously observed that HHV-8 encoded chemokine
signaling led to diminished Bim expression [12], immunofluores-
cence analysis of Bim expression in HHV-8 lytically infected
endothelial cells revealed that detectable Bim was largely
sequestered in the nuclei, rather than in the cytoplasm where it
is normally localized and known to function. Thus, co-staining for
Bim and K8.1 late lytic antigen, to identify cells supporting lytic
reactivation in HHV-8
+ telomerase-immortalized endothelial
(TIME) cells [22], enabled correlation of lytic infection with Bim
nuclear localization (Fig. 1A). Co-staining for early (vIRF-1,
ORF59) lytic antigens, in addition to K8.1, again demonstrated
Bim nuclear localization specifically in cells supporting lytic
reactivation, providing verification of this phenomenon (Fig. 1B).
Also revealed in this experiment was correspondence of nuclear
staining patterns of Bim and vIRF-1, suggesting the possible
involvement of vIRF-1 in Bim nuclear localization. It is worth
noting that while some cytoplasmic Bim staining was occasionally
detected in cells co-staining for lytic antigen, nuclear Bim staining
was always predominant, and nuclear-localized Bim was never
detected in mock-infected cultures (+TPA).
vIRF-1:Bim interactions
To investigate the potential role of vIRF-1 in mediating nuclear
localization of Bim, cotransfection assays (in HEK293T cells) were
employed. Expression vectors for BimEL [extra-large isoform [23],
Flag-tagged] and vIRF-1, in addition to other HHV-8 nuclear
proteins or GFP negative control, were utilized in these experi-
ments. Cytoplasmic versus nuclear distribution of Bim in the
absence and presence of the co-expressed viral proteins was
determined by immunoblotting of the respective fractions. The
results showed that vIRF-1, specifically, induced nuclear transloca-
tion of Bim (Fig. 2A). This was verified in intact cells by
immunofluorescence assay (IFA); vIRF-1, co-expressed with BimEL
in transfected cells, was able to induce nuclear translocation of the
BH3-only protein (Fig. 2B, top), consistent with the western data.
This effect was not seen with Puma, another pan-Bcl-2-binding
BH3-only protein, demonstrating specificity of the effects seen with
Bim(Fig. 2B,bottom). Whether vIRF-1was able tointeract (directly
or indirectly) with Bim was tested by utilizing glutathione-S-
transferase (GST)-fused bacterially-derived recombinant vIRF-1 in
co-precipitation assays. GST-vIRF-1 was added to lysates of Flag-
BimEL transfected HEK293T cells or to lysates of BCBL-1 (PEL)
cells [24], naturally expressing high levels of Bim, and glutathione
bead-precipitated material analyzed by immunoblotting. Bim was
co-precipitated in a vIRF-1-dependent manner (Fig. 2C). Evidence
of vIRF-1:Bim interaction was obtained also from immunoprecip-
itations from lysates of cells cotransfected with Flag-BimEL and
vIRF-1 expression vectors (Fig. 2D). Direct interaction between
vIRF-1 and Bim was demonstrated by co-precipitation assays
utilizing bacterially-expressed and purified proteins, fused to GST
and chitin-binding domain (CBD) sequences, respectively. vIRF-1
could be co-precipitated with CBD-fused Bim (short, long and
extra-long isoforms), but not with CBD alone, following sedimen-
tation with chitin beads (Fig. 2E). Together, these data provided
evidence of vIRF-1:Bim association and of vIRF-1-mediated Bim
nuclear translocation. That vIRF-1:Bim co-localization was seen in
cells lytically infected with HHV-8 (Fig. 1B) suggested biological
relevance of vIRF-1:Bim interaction.
Mapping of Bim-interacting region of vIRF-1
As vIRF-1 is known to interact with severalcellular proteins, such
as IRFs, p53, ATM, GRIM19 and Smads [25,9–11,26], precise
mapping of its interaction with Bim was necessary to enable
experimental assessment of the functional significance of vIRF-
1:Bim interaction, specifically. To this end, a series of successively
refined deletion variants of vIRF-1 were generated as bacterially
expressed GST-fusion proteins for use in in vitro co-precipitation
assays, along with CBD-fused BimEL. Full-length vIRF-1-GST and
derivatives containing the central region (residues 80–256) could be
co-precipitated with BimEL-CBD using chitin beads, demonstrating
involvement of these sequences in binding (Fig. 3A, top). Further
deletion analysis revealed that the central portion of this region was
sufficient for binding (Fig. 3A, middle). Based on this result,
sequences coding for overlapping 18-mer peptides derived from this
central portion were cloned to further map the Bim-binding
Author Summary
Human herpesvirus 8 (HHV-8) is a pathogen associated
with cancers Kaposi’s sarcoma (KS), an endothelial cell
disease, and B cell malignancies primary effusion lympho-
ma and multicentric Castleman’s disease. KS is particularly
prevalent amongst HIV-positive populations in Africa and
is a major health concern. Virus productive replication, in
addition to latency, is important for maintaining viral load
within the host and also for KS pathogenesis. Essential to
HHV-8 and other virus replication is the control of innate
host defenses, which comprise stress-sensing cellular
signaling pathways that result ultimately in programmed
cell death (apoptosis). Here we identify a novel mechanism
whereby a viral protein, viral interferon regulatory factor-1
(vIRF-1), mediates inhibition of a stress sensor and initiator
of apoptosis, Bim, by inducing its translocation to the cell
nucleus and thereby sequestration away from the cyto-
plasmic compartment where it exerts its pro-death activity.
We show that vIRF-1:Bim interaction is necessary for
efficient HHV-8 productive replication and that it can be
blocked using a cell-permeable antagonist of vIRF-1:Bim
binding. Our data not only identify previously unsuspected
mechanisms of Bim inactivation and vIRF-1 function, but
suggest that inhibitory targeting of vIRF-1 interaction with
Bim may be of therapeutic benefit.
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4) was sufficient for association with BimEL in this assay (Fig. 3A,
bottom). Mutations within this putative amphipathic a-helical
region were introduced to fine-map the Bim-binding region of
vIRF-1; mutation of the central residues (174–181) abrogated
interaction (Fig. 3B). Therefore, a region of vIRF-1 sufficient for
direct interaction with BimEL was mapped to vIRF-1 residues 170–
187, the core amino acids 174–181 of this Bim-binding domain
(BBD)beingrequiredforbinding.ThisregionofvIRF-1isdivergent
from collinear regions of other IRFs, both viral and cellular.
vIRF-1 BBD involvement in Bim nuclear localization
Next, the relevance of the BBD region to vIRF-1-mediated
nuclear localization of Bim was examined. First, the 170–187 BBD
of vIRF-1 was tested for its ability to bind to and effect nuclear
localization of Bim when linked to a nuclear localization signal
(NLS). Sequences encoding BBD and NLS were fused to the GFP
open reading frame in a eukaryotic expression vector; a vector
specifying GFP-NLS, lacking the 18-mer BBD coding sequence,
was made to provide a control. The former, specifically, was able to
induce nuclear translocation of BimEL in appropriately transfected
cells, as determined by IFA (Fig. 4A), demonstrating sufficiency of
themappedsequencesforinteractingwithBimELintracellularlyand
enabling its nuclear translocation (directed by NLS). The
requirement of the 174–181 region and core residues 178/179 of
vIRF-1 BBD for Bim nuclear translocation in the context of full-
length vIRF-1 was demonstrated in analogous experiments utilizing
wild-type and BBD core-deleted or -mutated vIRF-1 (Fig. 4B). The
requirement of these residues for Bim interaction was determined
directly by co-precipitation assay using lysates of HEK293T cells
transfected with expression vectors for wild-type or BBD-mutated/
deleted vIRF-1 proteins and Flag-tagged BimEL (Fig. 4C). Although
disrupting Bim interaction and nuclear localization by vIRF-1, the
substitution and deletion mutations had no significant effects on
functional interactions of vIRF-1 with p53, Smad3 and IRF-1
having potentially overlapping interactions with the central region
Figure 1. Nuclear localization of Bim during HHV-8 productive replication. (A) Telomerase-immortalized endothelial (TIME) cells latently
infected with HHV-8 were treated with TPA to induce lytic replication. Cells supporting lytic reactivation were identified by immunofluorescence
staining for K8.1 late lytic membrane protein and Bim was detected by co-staining with appropriate immunological reagents (see Materials and
Methods), six days after lytic induction. The left panel shows merged immunofluorescence staining for K8.1 (green) and Bim (red) together with
Hoechst nuclear staining (blue). The right panels show individual staining for K8.1 and Bim, emphasizing the correlation of Bim nuclear staining with
lytic antigen (K8.1) expression. (B) Analogous confocal immunofluorescence analyses verified Bim nuclear localization specifically in lytically
reactivated cells, expressing ORF59-encoded and vIRF-1 early nuclear antigens in addition to K8.1 late membrane protein, and revealed colocalization
of vIRF-1 and Bim staining patterns.
doi:10.1371/journal.ppat.1001031.g001
vIRF-Induced Nuclear Translocation and Inactivation of Bim
PLoS Pathogens | www.plospathogens.org 3 August 2010 | Volume 6 | Issue 8 | e1001031Figure 2. vIRF-1 induced Bim nuclear localization and vIRF-1:Bim interaction. (A) vIRF-1 and selected other HHV-8 nuclear proteins, or GFP
(negative control), were tested for their abilities to induce nuclear translocation of BimEL-Flag in transfected HEK293T cells by western analysis of
cytoplasmicandnuclearfractions of transfectedcells. vIRF-1,specifically, induced nuclear localizationof Bim. (B)IFA-determined nuclear translocation of
Flag-BimEL(butnot Flag-Puma,controlBH3-onlyprotein)inducedbyvIRF-1inexpression vector-transfectedHEK293T cells.Nuclear localizationofBimin
vIRF-1 co-transfected cells correlated with strong nuclear vIRF-1 staining. (C) Physical association of vIRF-1 and Bim was detected by co-precipitation
assay employing GST-fused vIRF-1mixed with extracts of Flag-BimEL vector-transfectedHEK293T or untransfectedBCBL-1cells [24], the latter expressing
high levels of endogenous Bim. Western analysis of glutathione bead-precipitated material identified Bim precipitated with GST-vIRF-1 protein, but not
with GST alone (top panels). Lower panels show precipitated GST protein; bracketed bands (*) correspond to GST-vIRF-1 protein degradation products.
(D) Association of Bim and vIRF-1 in intact cells as evidenced by vIRF-1 co-precipitation with Flag antibody-immunoprecipitated (IP) Flag-BimEL from cell
lysate of appropriately transfected cells. Cntl IgG, control (non-specific) IgG. (E) In vitro binding assay using bacterially expressed and purified
recombinant GST-vIRF-1 and chitin-binding domain (CBD)-fused BimS, BimL and BimEL isoforms, precipitable with chitin beads. All Bim-CBD
constructions, but not CBD alone, were able to co-precipitate GST-vIRF-1, demonstrating direct binding of each Bim isoform to vIRF-1.
doi:10.1371/journal.ppat.1001031.g002
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disrupted vIRF-1 interaction with Bim specifically.
Apoptotic regulation via vIRF-1:Bim interaction
The functional consequence of vIRF-1 expression on cell viability
and apoptosis in response to BimEL was examined using GFP- and
TUNEL-based assays. In the former, GFP expression and fluores-
cence wasdiminished as a function of BimELplasmid transfection and
therefore the proportion of GFP
+ cells in the population, determined
by counting of cells under UV microscopy (and using co-staining with
Hoechst to visualize nuclei), provided a measure of cell viability. Both
apoptosis (identified by TUNEL staining) and cell viability were
inhibited significantly (.50% under the conditions used) by vIRF-1
co-expression (Fig. 5A). Using the GFP viability assay and quantifying
Figure 3. Mapping Bim interaction site of vIRF-1. (A) Recombinant GST-vIRF-1 (progressively deleted) and BimEL-CBD proteins were used in co-
precipitation-based binding experiments to determine the ‘‘Bim-binding domain’’ (BBD) of vIRF-1. The C-terminal hydrophobic region of BimEL (last
18 amino acids) was deleted to enhance solubility of the protein in bacteria. The binding assay employed was analogous to that of Fig. 2E. (B)
Mutations introduced into the deletion-mapped BBD (residues 170–187) identified residues 174–181 as necessary for interaction with Bim.
doi:10.1371/journal.ppat.1001031.g003
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type vIRF-1, the Bim-refractory vIRF-1 deletion and point variants,
vIRF-1(D174-181) and vIRF-1(GK179AA), were unable to inhibit of
BimEL-induced cell death (Fig. 5B).That nuclear translocation of Bim
induced by vIRF-1 could theoretically account for the observed
decrease in BimEL-induced apoptosis was verified utilizing an NLS-
fused version of BimEL, which accumulated predominantly in the
nuclei of transfected cells (Fig. 5C, left). This construction was greatly
impaired relative to native BimEL with respect to apoptotic induction,
although expressed equivalently (Fig. 5C, middle and right panels),
confirming the inhibitory effect of nuclear sequestration of the
normallycytoplasmic protein. Combined, these data suggest that pro-
apoptotic functions of Bim are lost upon nuclear localization and that
inhibition of Bim activity by vIRF-1 is mediated via direct interaction
that enables cytoplasmic-to-nuclear translocation of the BH3-only
protein by vIRF-1.
Relevance of vIRF-1:Bim interaction to virus replication
To address biological significance, vIRF-1 function and vIRF-
1:Bim interaction in the context of HHV-8 lytic replication were
Figure 4. Sufficiency and requirement of vIRF-1 BBD for Bim interaction. (A) Sufficiency of BBD for Bim binding intracellularly was
determined by immunofluorescence assay (IFA) in cells transfected with plasmid vectors expressing nuclear localization signal (NLS)-fused BBD (also
linked to GFP) and Flag-BimEL. NLS-GFP was used as a negative control. (B) Analogous IFA studies employing BBD core residue-deleted (D174-181) or -
substituted (GK179AA) versions of vIRF-1 verified the importance of BBD in the context of full-length vIRF-1 for interaction with and nuclear
localization of Bim. (C) BBD-altered vIRF-1 proteins also were unable to bind BimEL in immunoprecipitation (IP) binding assays (analogous to those in
represented in Fig. 2D). (D) Reporter assays were used to assess the specificity of effects of BBD alteration, as BBD lies within (large) regions of vIRF-1
previously shown to interact in inhibitory fashion with p53, Smads 3 and 4, and IRF-1 [25,10,11]. Luciferase reporters responsive to these proteins
were inhibited equivalently by wild-type and BBD-mutated vIRF-1 proteins, in the presence of p53, Smad3 or IRF-1. Results are from three
transfections; error bars represent standard deviations from means values.
doi:10.1371/journal.ppat.1001031.g004
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1-targeted shRNAs for vIRF-1 depletion, or non-silencing (NS)
control shRNA, to determine whether vIRF-1 contributed
detectably to virus productive replication in culture. TPA-induced
virus production from HHV-8 latently infected telomerase
immortalized endothelial (TIME) cells was markedly reduced in
vIRF-1-depleted relative to control (NS shRNA-transduced)
cultures, as determined by qPCR applied to DNaseI-pretreated
and -resistant (encapsidated) viral DNA (Fig. 6A).
Having identified pro-replication activity of endogenously
produced vIRF-1, we next generated TIME cell cultures
expressing Dox-inducible vIRF-1, vIRF-1(D174-181) or vIRF-
1(GK179AA) to assess the relative abilities of the wild-type and
Bim-refractory vIRF-1 proteins to enhance HHV-8 productive
replication. While all proteins enhanced virus production in Dox-
treated cells, the Bim-refractory vIRF-1 variants were significantly
less active, demonstrating the contribution and importance of Bim
interaction, specifically, to pro-replication activity (Fig. 6B, top).
Western analysis of Bim nuclear localization in these cultures
revealed vIRF-1-enhanced nuclear localization of Bim, relative to
empty vector (EV) control, and apparent reductions of nuclear
Bim in cultures expressing the BBD variants of vIRF-1. The latter
suggests possible dominant negative activity of these Bim-
refractory proteins, although the mechanism that might be
involved is not clear. Nonetheless, these data demonstrate that
vIRF-1 is able to induce nuclear localization of Bim in the context
of virus productive replication. In parallel experiments, apoptosis
induced in infected cells (positive for latency-associated nuclear
antigen, LANA) upon TPA treatment was substantially reduced in
vIRF-1 overexpressing cultures (+Dox), but the BBD-mutated
vIRF-1 proteins displayed little or no activity (Fig. 6C). These data
implicate vIRF-1:Bim interactions as centrally important for vIRF-
1-mediated protection from lytic cycle-induced apoptosis. In
shRNA-depleted cultures, rates of apoptosis upon TPA treatment
of HHV-8 infected TIME cultures were induced ,2.5-fold
relative to control NS shRNA-transduced cultures, revealing the
significant contribution of endogenously expressed vIRF-1 to
suppression of lytic cycle-induced apoptosis (Fig. 6D). Together,
these data indicate that vIRF-1 and vIRF-1:Bim interaction,
specifically, are effective mediators of apoptotic inhibition during
lytic replication and, in combination with the replication
experiments (Fig. 6B), that this is important for establishing
conditions conducive to efficient virus production.
Inhibition of vIRF-1:Bim interaction
The role of vIRF-1:Bim interaction, specifically, independent of
vIRF-1 interactions with other cellular proteins, was further
demonstrated by addition in replication experiments of Tat-fused
(cell-permeable) peptides corresponding to Bim-interacting vIRF-1
Figure 5. Functional significance of vIRF-1:Bim binding and Bim nuclear translocation. (A) vIRF-1 inhibition of Bim-induced cell death and
apoptosis was identified using GFP-based cell viability and TUNEL assays, respectively. The left panels show examples of fluorescence microscopy
results from which quantified data (right panels, charts) were derived. (B) Using the GFP-based assay and quantifying GFP fluorescence by
fluorometry, Bim-inhibitory activity of wild-type vIRF-1 was compared against activities of BBD-altered vIRF-1(GK179AA) and vIRF-1D174-181. The
latter were unable to inhibit BimEL activity. (C) Using the same assay, the functional consequence of nuclear translocation of Bim was tested using an
NLS-fused version of BimEL (Flag-tagged, ‘‘fBim’’). NLS-fBimEL, localizing predominantly in the nuclei of transfected cells as expected (IFA, bottom
panels), was significantly inhibited relative to native fBimEL in respect of pro-death activity (chart, middle panel). Results are expressed in relation to
GFP fluorescence values (100%) derived from control cultures transfected with empty vector instead of Bim vectors. Western blotting (right panels)
verified equivalent expression of native and NLS-fused versions of Flag-tagged BimEL; fBim- and NLS-fBim-containing extracts were processed
identically and in parallel, and therefore band intensities are directly comparable. Data from apoptosis assays were derived from triplicate (panels A
and B) or duplicate (panel C) transfections; error bars show standard deviations from mean values. GFP fluorescence measurements were undertaken
24 h posttransfection (panels B and C).
doi:10.1371/journal.ppat.1001031.g005
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lent. The wild-type peptide, specifically, led to reduced virus titers
(Fig. 7). Again, these data indicate that vIRF-1:Bim interaction
and inhibition of Bim pro-apoptotic activity are important for
virus productive replication. The results further suggest that
disruption of vIRF-1:Bim, perhaps through the use of small
molecule inhibitors, could potentially provide a means to inhibit
virus replication specifically and for therapeutic benefit.
Discussion
HHV-8 encoded viral interferon regulatory factors have been
noted previously to interfere with innate immune responses of
cells, in particular via their inhibition of activities of cellular IRFs,
necessary for interferon induction and consequent cell cycle arrest
and apoptosis [6,8]. vIRF-1 has been reported to interact with a
broad range of proteins in addition to cellular IRFs; these other
proteins include p53, ATM, TGFb-activated Smad transcription
factors, and GRIM19 [25,9,10,26], all of which play roles in
mediating innate immune functions via regulation of cell cycle and
apoptosis. These activities, induced by infection, presumably must
be controlled sufficiently by the virus to allow productive
replication in the face of stress signaling. Bim, induced strongly
and rapidly following HHV-8 lytic reactivation in latently infected
endothelial cells, is a powerful inhibitor of HHV-8 production in
this cell type and thus represents a biologically relevant target of
vIRF-1 [12]. The data presented here indicate that vIRF-1:Bim
interaction is indeed important in the context of virus replication,
being necessary for substantial or major proportions of replication-
enhancing and anti-apoptotic activities specified by vIRF-1 in
lytically reactivated endothelial cells. Thus, vIRF-1 regulation of
Bim pro-apoptotic function represents a critical component of
vIRF-1 activity and one which is essential for normal virus
productive replication, at least in this cell type.
To our knowledge, this is the first demonstration of interaction
between an IRF homologue and a member of the Bcl-2 family, and
the first report of nuclear translocation of Bim or any other Bcl-2
related protein as a means of functional inactivation. Whether
physiological conditions unconnected with viral infection can
promote such nuclear localization and inactivation is unclear; none
has been reported to date. On the other hand, several previous
investigations have noted the nuclear localization and functions of
Bcl-2 family members. Bcl-2 nuclear localization can occur during
oxidative stress, Bcl-2 overexpression or loss of interaction with
mitochondrial-localizing protein FKBP38, with promotion of
apoptosis via blocking of nuclear trafficking of transcription factors
[28–31]. Mcl-1 has been reported to inhibit cell proliferation via
inhibitory interactions with proliferating cell nuclear antigen and
cyclin-dependentkinase1[32–34],whereastheBcl-2-relatedprotein
Bok, which cannot heterodimerize with Bcl-2 or Bcl-xL, can localize
to and function in the nucleus to promote apoptosis [35]. A splice
variant of Bfl-1, Bfl-1S, in which mitochondrial-localizing hydro-
phobic C-terminal sequences are replaced with a basic nuclear-
localization signal, may mediate anti-apoptotic activity via nuclear
sequestration of components of the apoptotic cascade [36]. Nuclear-
localized pro-death activity of apoptotic effector Bax has been
proposed due to correlation of Bax nuclear translocation in response
to alkylating agent (BCNU) with glioma cell sensitivity to the
Figure 6. vIRF-1 function and significance of vIRF-1:Bim interaction in the context of virus infection. (A) Two lentiviral-cloned shRNAs
effective for vIRF-1 depletion (top panels) were transduced into HHV-8 (latently) infected TIME cells and lytic reactivation then induced with TPA. After
six days, encapsidated (DNaseI-resistant) viral genomes released into culture media were quantified by qPCR [12]. vIRF-1 shRNA-specific reductions of
viral titers were observed. NS, non-silencing shRNA control. Data were obtained from triplicate qPCR reactions; error bars show standard deviations
from mean values. (B) Effects of wild-type and BBD-altered [GK197AA (‘‘AA’’) and D171-184 (‘‘D’’)] vIRF-1 proteins on virus replication were tested using
TIME cell lines expressing each of the proteins in a doxycycline (Dox)-inducible fashion. EV, empty vector control. Data were derived from triplicate
PCR reactions; error bars show deviations from mean values. Western analysis of nuclear extracts revealed induced nuclear localization of
endogenous Bim only in wild-type vIRF-1 expressing cells. (C) In analogous experiments, TUNEL analysis of apoptosis revealed effective protection
from lytic cycle-induced apoptosis (+TPA) by overexpression of wild-type vIRF-1 (+Dox), but not by Dox-induced vIRF-1 variants GK179AA or D174-181.
Data were derived from multiple random fields for each condition; error bars represent standard deviations from mean values. (D) Similar analysis of
apoptosis in vIRF-1-depleted and control non-silencing (NS) shRNA-transduced TIME cultures revealed significantly increased rates of HHV-8
replication-induced apoptosis in vIRF-1 shRNA (sh1, sh2) expressing cultures, demonstrating anti-apoptotic function of endogenously expressed vIRF-
1. Data were derived multiple random fields from duplicate cultures; error bars reflect deviations from mean values obtained from each.
doi:10.1371/journal.ppat.1001031.g006
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localization of Bcl-2 family proteins, both pro- and anti-apoptotic,
along with evidence of function in this compartment, the induced
nuclear localization and inactivation of BH3-only protein Bim
identified here appears to be unique and the first example of viral
control of apoptosis via nuclear sequestration of a Bcl-2 family
member. That a viral IRF homologue mediates this effect is also a
novel finding. Our demonstration that vIRF-1:Bim interaction is
both important for virus productive replication and can be inhibited
via peptide-mediated disruption suggests that targeting vIRF-1:Bim
interaction may provide a useful antiviral strategy.
Materials and Methods
Plasmids and expression vectors
Two short hairpin RNAs (shRNA) for vIRF-1 were cloned into
pYNC352/puro (a derivative of pYTF [38]) using BamHI and
MluI enzyme sites; target sequence of the shRNAs correspond to
59- AGCCGGACACGACAACTAAGA -39 (sh1) and 59-AT-
CAAGGATTGGATAGTATGT-39 (sh2). Sequences specifying
wild-type or mutated forms of vIRF-1 were cloned into lentivirus
vector pYNC352/SV40/puro using MluI and BamHI cloning sites.
BimEL cDNA sequences linked to Flag were cloned between the
BamHI and EcoRI sites of pcDNA3.1 (Invitrogen; Carlesbad, CA),
for expression in transfected cells. Coding sequence for the nuclear
localization signal (NLS) of SV40 large T antigen was inserted
between the HindIII and BamHI sites of pcDNA3.1-flag-BimEL to
generate a eukaryotic expression vector encoding NLS-flag-BimEL.
Bacterial expression plasmids for BimEL and vIRF-1 were
generated by cloning of the respective coding sequences into
pTYB4 (New England Biolabs; Ipswich, MA) and pGEX-4T-1
(GE Life Sciences; Piscataway, NJ), using NcoI and SmaI sites and
BamHI and EcoRI sites, respectively. The BimEL and vIRF-1
proteins were fused to intein/chitin-binding-domain (CBD) and
GST, respectively, used for precipitation and purification via
chitin- and glutathione-bead capture. Fas ligand promoter
sequences encompassing 1.2-kb upstream of the initiator codon
[39] were amplified from BCBL-1 cell DNA by PCR and cloned
between the XhoI and HindIII sites of pGL3/basic to provide a
reporter construction responsive to IRF-1. The NLS and BBD
coding sequences were cloned between KpnI and AgeI and BsrGI
and XbaI sites, respectively, of pEGFP-N1 (Clontech Laboratories;
Mountainview, CA) to generate nuclear-directed GFP and GFP-
BBD proteins. Coding sequences for wild-type or mutated vIRF-1
proteins were cloned between the BamHI and MluI sites of
pRetroX-Tight-Pur (Clontech Laboratories) to construct viral
vectors for the generation of TIME cultures conditionally
expressing the proteins (+Dox).
Cell culture, transfection and viral transduction
TIME cells [22] were maintained in EGM-2 MV medium
(Lonza, Walkersville, MD) containing 5% fetal bovine serum (FBS)
and cytokine supplements. HEK293 and HEK293T cells were
grown in Dulbecco’s modified Eagle’s medium supplemented with
10% FBS and gentamicin. BCBL-1 cells [24] were cultured in
RPMI 1640 supplemented with 20% heat-inactivated FBS and
gentamicin. For lentivirus production, HEK293T cells were
transiently transfected with virus vector and gag/pol-encoding
packaging plasmids using standard calcium-phosphate precipita-
tion method and virus harvested after 48 h by centrifugation at
49,0006g, essentially as described previously [12]. Other trans-
fections were performed using Lipofectamine 2000 (Invitrogen).
Stable transduction of shRNA or cDNA into TIME cells using
lentivirus vectors was performed under puromycin selection.
Cell extracts, immunoblotting and immunofluorescence
For whole cell extracts, cells were lysed in lysis buffer (50 mM
Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM EDTA, 1% IGEPAL
CA-630, 0.25% sodium deoxycholate, and protease inhibitor
cocktail). For nucleo-cytoplasmic fractionation, cells were homog-
enized in buffer A (10 mM HEPES [pH 8.0], 1.5 mM MgCl2,
10 mM KCl, 0.5 mM DTT, and protease inhibitor) using a
Dounce homogenizer. After centrifugation of the homogenate at
1,5006g, the supernatant was used as the cytoplasmic fraction and
the pellet, after resuspended in buffer B (20 mM HEPES [pH 8.0],
1.5 mM MgCl2, 420 mM NaCl, and 0.2 mM EDTA), was used as
the nuclear fraction. For immunoblotting, proteins were size
fractionated by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and transferred to a nitrocellulose
membrane. Immunoreactive bands were detected with enhanced
chemiluminescence solution (GE Healthcare, Piscataway, NJ) and
Figure 7. BBD peptide-mediated disruption of vIRF-1:Bim
interaction. The biological significance of Bim binding by vIRF-1 and
feasibility of targeted disruption of vIRF-1:Bim interaction were tested
using cell-permeable (Tat-fused) BBD peptides,wild-type and AA-mutated.
These were applied (at 10 mM final concentration) to HHV-8 infected TIME
cultures prior to TPA induction. Inhibition of virus production specifically
by wild-type BBD (top) reflected the relative abilities of the wild-type and
mutated peptides to interfere with vIRF-1:Bim interaction in vitro (lower
panels). Replication data were derived from triplicate PCR reactions; error
bars indicate deviations from mean values.
doi:10.1371/journal.ppat.1001031.g007
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cells on a 0.1% gelatin-coated coverglass were fixed and
permeabilized in chilled methanol. Following incubation with
superblock blocking buffer (Thermo Scientific Inc., Rockford, IL),
coverslips were incubated with primary antibody, washed with
phosphate-buffered saline (PBS), and then incubated with
appropriate fluorescent dye-conjugated secondary antibody.
Coverslips were mounted in 90% glycerol in PBS containing
10 mg/ml p-phenylenediamine. Nuclei were visualized by staining
with Hoechst 33342.
HHV-8 infection, replication, and quantitative PCR
Infectious HHV-8 was obtained by inducing BCBL-1 cells with
phorbol 12-myristate 13-acetate (PMA/TPA; 20 ng/ml) and calcium
ionophore (A23187; 500 ng/ml). After 20 h, cells were pelleted and
resuspended in fresh medium without TPA and A23187. After four
days, virions were pelleted from culture media by centrifugation at
27,0006g for 2 h in an SW41 rotor and resuspended in basal EGM-
2 MV medium. For HHV-8 infection, TIME cells were centrifuged
at 1,0006g for 1 h in the presence of HHV-8 virions, and then
cultured in fresh complete medium for 7 days to allow establishment
of latency in the absence of ongoing lytic replication. Lytic replication
of HHV-8 in TIME cells was induced by treatment with TPA. For
determination of encapsidated HHV-8 genome copy number, viral
DNA was extracted using guanidinium thiocyanate (6M) and silica
gel following pre-treatment of virus suspensions with DNaseI for
20 min. at 37uC. Excess HHV-8 bacmid DNA was treated with
DNaseI and processed identically to control for DNaseI efficacy. All
qPCRs were performed in a 96-well microplate using an ABI Prism
7500 detection system (Applied Biosystems; Foster City, CA) with
SYBR green/ROX master mix (SuperArray Bioscience Corp.;
Frederick,MD).Reactionswereperformedinatotalvolumeof25 ml,
containing viral DNA sample and 250 nM of each primer. To
calculate copy number of viral DNA, BAC-cloned HHV-8 genomic
DNA was used as a standard. PCR conditions included an initial
incubation step of 2 min. at 50uC, and enzyme heat activation step of
10 min at 95uC, followed by 45 cycles of 15 seconds at 95uCf o r
denaturing and 1 min at 60uC for annealing and extension.
Reporter assay
HEK293T cells were transiently transfected with plasmids
expressing vIRF-1 and p53, Smad3 or IRF-1 along with reporter
plasmids, PG13-luc (Addgene; Cambridge, MA), SBEx4-luc
(Addgene), or Fas ligand promoter-luc (see above), respectively,
for 24 h and then lysed with passive lysis buffer (Promega,
Madison, WI). Luciferase activity was measured by standard
methods using D-luciferin and luminometry.
Cell viability assay
Bim-induced cell death of HEK293 cells was monitored by
cotransfection of pEGFP-N1 (Clontech laboratories, Mountain
view, CA) and measuring fluorescence by fluorometry. For
terminal deoxynucleotidyltransferase (TdT)-mediated dUTP-bio-
tin nick end labeling (TUNEL), cells were fixed in chilled
methanol for 5 min and preincubated in TdT reaction buffer
(25 mM Tris-HCl [pH 6.6], 200 mM sodium cacodylate,
0.25 mg/ml BSA, and 1 mM CoCl2) for 10 min. TUNEL
reactions were carried out at 42uC for 2 h in TdT reaction buffer
containing TdT and biotin-dUTP (Roche, Indianapolis, IN) and
terminated with stop solution (300 mM NaCl and 30 mM sodium
citrate). TUNEL-positive cells were visualized by staining with
FITC-avidin. LANA IFA was performed after TUNEL reactions,
using LANA monoclonal antibody (Advanced Biotechnologies Inc;
Columbia, MD) and staining with Cy-3-conjugated secondary
antibody.
Protein co-precipitation assay
Glutathione-S-transferase (GST)-fusion proteins were purified
by standard methods. Proteins from BimEL-transfected HEK293T
or BCBL-1 cells were incubated with purified GST or GST-vIRF-
1 proteins immobilized on glutathione beads. After washing with
lysis buffer, the bead-precipitated material was subjected to SDS-
PAGE and analyzed by immunoblotting using Bim- or GST-
specific antibodies. For binding-site mapping, BimEL (lacking the
C-terminal 18 residues, affecting solubility) was fused to intein-
chitin binding domain (CBD) in pTYB4 and purified according to
the manufacturer’s protocol. GST or a series of GST-vIRF-1
fusions were incubated with the purified Bim protein immobilized
on chitin beads. After washing with lysis buffer, bead-associated
proteins were size-fractionated by SDS-PAGE and analyzed by
immunoblotting using GST- or CBD-specific antibodies. For
peptide competition assays, peptides (35-fold molar excess) were
pre-incubated with BimEL-intein-CBD for 1 h before addition of
GST-vIRF-1. Peptide sequences (the first 11 residues comprising
Tat basic region) were: BBD-WT, YGRKKRRQRRRGGG-
RTRGLQEIGKGISQDGHH; BBD-Mut, YGRKKRRQRRR-
GGGRTRGLQEIAAGISQDGHH (altered residues underlined).
For immunoprecipitation, HEK293T cells transfected with
plasmids expressing Flag-BimEL or vIRF-1 were lysed in lysis
buffer and cell extracts were incubated with anti-Flag antibody
(M2) and immune-complexes precipitated with protein A/G-
agarose. After washing with lysis buffer, immune-complexes were
subjected to SDS-PAGE and analyzed by immunoblotting using
vIRF-1 antiserum, Bim antibody or biotinylated Flag antibody and
secondary, detection reagents comprising HRP-conjugated anti-Ig
antibody or sptreptavidin-HRP.
Reagents
K8.1 and LANA antibodies were purchased from Advanced
Biotechnologies Inc (Columbia, MD). Antisera directed to vIRF-1
and ORF59 were provided by Drs. Gary Hayward and Bala
Chandran, respectively. Actin and Flag antibodies were purchased
from Sigma (St. Louis, MO), HDAC1 and GST antibodies from
Santa Cruz Biotechnologies, Inc. (Santa Cruz, CA), Bim antibody
from Cell Signaling Technologies, Inc. (Beverly, MA), GFP
antibody from Epitomics, Inc. (Burlingame, CA), and CBD
antibody from New England Biolabs, Inc. (Ipswich, MA).
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